Changes to the long-stay antipsychotic quality measure are reshaping how facilities track and report antipsychotic use and raising the stakes for accurate documentation and prescribing practices. In this month’s Compliance Cue, learn what the latest updates mean for quality measures, survey readiness, and regulatory compliance, along with key steps your team can take to stay ahead of evolving expectations.